
51 - 200 employees
Founded 2018
🏥 Healthcare
💼 Consulting
🧬 Biotechnology
💰 $46M Series B on 2023-10
Healthcare • Consulting • Biotechnology
Angitia Biopharmaceuticals is a clinical-stage biotechnology company founded in 2018, focused on the discovery and development of breakthrough therapeutics for serious musculoskeletal diseases. With a strong emphasis on innovation, Angitia aims to address unmet medical needs through their pipeline of therapeutics, including treatments for conditions such as Osteogenesis Imperfecta and Osteoarthritis. The company is devoted to fostering a culture of respect and equality, and is committed to employee growth and career development while delivering effective therapies to help patients in need.
📡 We watch Angitia Biopharmaceuticals's careers page
Every 2 hours
how often we check
1
roles posted in the last 30 days
About 34 days
usual time to fill a role
10
roles closed in the last year
Selected: 🆕 Date Added.
🕒 Yesterday
Senior regulatory writer leading IND-to-marketing submissions for Angitia, a biotechnology company developing therapies for serious musculoskeletal diseases. Coordinating cross-functional regulatory documents and agency interactions.
🏄 California – Remote
💵 $130k - $150k / year
💰 $46M Series B on 2023-10
⏰ Full Time
🟠 Senior
✏️ Content Writer
👻 Ghost score 0%
🕒 October 5
Global Regulatory Affairs Director leading regulatory strategies and submissions for Angitia’s clinical-stage musculoskeletal disease therapeutics. Guiding global health authority interactions and development programs.
🇺🇸 United States – Remote
💵 $180k - $230k / year
💰 $46M Series B on 2023-10
⏰ Full Time
🔴 Lead
🚔 Compliance
👻 Ghost score 4%